Dr. Ares leads the Radiation Oncology Department at Quironsalud Proton Therapy Centre – a world leader in proton therapy.

• 32 years of experience specializing in proton therapy for precise tumor targeting
• Trained at Massachusetts General Hospital's proton therapy center
• Published 34+ research papers in peer-reviewed journals
• Head of department at Spain's premier proton therapy facility

1,100+ oncological treatments performed – Dr. Sapra specializes in gynecologic cancers and radiotherapy at Sourasky Medical Center, ranked among Forbes' top 5 hospitals.

• Dual specialist in oncological gynecology and radiotherapy
• 39 years of experience focused on female reproductive cancers
• Faculty member at Tel Aviv University
• Member of leading societies SGO and ASCO

Dr. Altay Aliyev combines targeted therapies and immunotherapy with research-backed protocols at Liv Bona Dea Hospital Baku.

• Trained at Cleveland Clinic and Istanbul University
• Published multiple studies on thyroid and breast cancer treatments
• Expert in cytotoxic chemotherapy and hormone therapy
• Focuses on early diagnosis and palliative care

Board certified in both Internal Medicine and Cardiology, Dr. Aballay has over 42 years of experience of experience treating complex medical conditions.

• Specializes in cardiology, pulmonology, and critical care medicine
• Provides comprehensive care at Sourasky Medical Center in Tel Aviv
• Fluent in both English and Spanish for clear communication

Specializing in bone cancer treatments, Dr. Sokucu brings advanced orthopedic techniques to complex cases at VM Medical Park Florya Hospital.

• Over 23 years of experience of experience in orthopedics and traumatology
• Published 20+ research papers on orthopedic treatments and bone disorders
• Board-certified by the European Board of Orthopaedics and Traumatology
• Fellowship-trained in osteosynthesis and bone disease management

Dr. Aydogdu specializes in early detection of cancer in children, a critical aspect of pediatric oncology.

• Focuses on presentations and discussions about pediatric cancer detection
• Works at Liv Bona Dea Hospital Baku
• Contributes to advancements in pediatric oncology

Professor Mehmet Karaca specializes in minimally invasive laparoscopic techniques for gynecological cancers at Medical Park Antalya Hospital Complex.

• Trained in gynecological oncology surgery by the Ministry of Health
• 31 years of experience of experience in obstetrics and gynecology
• Expertise includes high-risk pregnancies and robotic-assisted hysterectomies
• Former clinical chief at Antalya Training and Research Hospital
• Holds a PhD in Obstetrics and Gynecology from Dicle University

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Specializes in oncothermia – a cutting-edge hyperthermia therapy for cancer – with 19 years of experience of focused experience at Panacee Hospital Rama2.

• 19 years of experience of expertise in advanced radiotherapy techniques
• Certified in Oncotherm therapy – a rare hyperthermia treatment approach
• Skilled in complex treatment planning (IMRT, VMAT, 2D/3D)
• Trained in palliative care at Khon Kaen University
• Provides comprehensive care including immunotherapy and chemotherapy

3,500+ robotic surgeries performed – Dr. Tvaruzek is a leading certified expert by Intuitive Surgical, the maker of the Da Vinci robot.

• Heads the Center of Robotic Surgery at St. Zdislava Hospital
• Specializes in prostatectomy with preservation of erectile function
• Performs transoral surgeries for tumors in the nasopharynx, larynx, trachea, and mouth
• Member of the Association of Aesthetic Medicine and Bariatric Surgery

Dr. Mazal pioneered proton therapy techniques globally, serving as Technical Director at Institut Curie's Proton Therapy Center for over 42 years of experience.

• 140+ scientific publications in radiation oncology
• Chairman of PTCOG – the leading particle therapy research group
• Developed protocols used in proton centers worldwide
• Advises treatment centers across 10+ countries
• Secured €50M+ in research funding for advanced therapies

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Zhang Yanjun, MD, is a Chief Physician and Master’s Supervisor with 30 years of experience in tumor imaging and radiation oncology. He treats both pediatric and adult patients. His focus includes primary and secondary tumors, neuro-oncology, and stereotactic radiotherapy.

He is proficient in radiotherapy for cancers of the lung, liver, nasopharynx, head and neck, esophagus, breast, rectum, cervix, and prostate, as well as lymphoma and central nervous system tumors.

He is a member of the Central Nervous System Tumor Radiotherapy Group of the Second Committee of the Radiation Oncology Physicians Branch of the Chinese Medical Doctor Association. He serves on the Executive Committee of the First Chinese Oncology Radiation Therapy Cooperation Group of the World Association of Chinese Oncology Physicians. He is also a member of the National Digestive Oncology Expert Committee of the Radiation Oncology Professional Committee of the Wu Jieping Medical Foundation. He was a visiting scholar twice at leading U.S. cancer radiotherapy centers. He has published 46 papers in core journals and international conferences.

Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.

He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.

Over 17 years of experience specializing in robotic and minimally invasive urologic surgeries at German Oncology Centre.

• Fellow of the European Board of Urology and Royal College of Surgeons
• Expert in prostate cancer treatments, including robotic-assisted procedures
• Lead investigator in MULTIPROS study for advanced biopsy techniques
• Honorary Senior Lecturer at St Andrews University

Prof. Sezer Sağlam specializes in gastrointestinal oncology with over 27 years of experience of experience, focusing on complex cases at Gayrettepe Florence Nightingale Hospital.

• Professor of Medical Oncology since 2016
• Fellowship-trained at Istanbul University – one of Turkey's top medical schools
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society
• Attending physician in Gastrointestinal Oncology at Istanbul University Oncology Institute

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Specializes in integrative cancer treatments at Biological Medicine - Integrative Health Center Baku, combining mistletoe therapy and high-dose vitamin C with conventional methods.

• Expert in hormonal treatments for breast cancer
• Skilled in managing chemotherapy and radiation therapy side effects
• Participant in international conferences with German and Turkish doctors
• Uses natural pain relief and life extension methods for cancer patients